Advertisement
Loading...

HeartBeam, Inc.

BEATNASDAQ
Healthcare
Medical - Healthcare Information Services
$0.96
$-0.08(-7.21%)
U.S. Market opens in 61h 29m

HeartBeam, Inc. Fundamental Analysis

HeartBeam, Inc. (BEAT) shows weak financial fundamentals with a PE ratio of -1.95, profit margin of 0.00%, and ROE of -10.34%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

PEG Ratio-0.07

Areas of Concern

ROE-10.34%
Operating Margin0.00%
Current Ratio0.74
We analyze BEAT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1010.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1010.9/100

We analyze BEAT's fundamental strength across five key dimensions:

Efficiency Score

Weak

BEAT struggles to generate sufficient returns from assets.

ROA > 10%
-5.15%

Valuation Score

Excellent

BEAT trades at attractive valuation levels.

PE < 25
-1.95
PEG Ratio < 2
-0.07

Growth Score

Moderate

BEAT shows steady but slowing expansion.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
15.07%

Financial Health Score

Moderate

BEAT shows balanced financial health with some risks.

Debt/Equity < 1
0.00
Current Ratio > 1
0.74

Profitability Score

Weak

BEAT struggles to sustain strong margins.

ROE > 15%
-1034.04%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is BEAT Expensive or Cheap?

P/E Ratio

BEAT trades at -1.95 times earnings. This suggests potential undervaluation.

-1.95

PEG Ratio

When adjusting for growth, BEAT's PEG of -0.07 indicates potential undervaluation.

-0.07

Price to Book

The market values HeartBeam, Inc. at 62.16 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

62.16

EV/EBITDA

Enterprise value stands at -1.75 times EBITDA. This is generally considered low.

-1.75

How Well Does BEAT Make Money?

Net Profit Margin

For every $100 in sales, HeartBeam, Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-10.34 in profit for every $100 of shareholder equity.

-10.34%

ROA

HeartBeam, Inc. generates $-5.15 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.15%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.34 in free cash annually.

$-0.34

FCF Yield

BEAT converts -41.37% of its market value into free cash.

-41.37%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.95

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

62.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.74

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-10.34

vs 25 benchmark

ROA

Return on assets percentage

-5.15

vs 25 benchmark

ROCE

Return on capital employed

-32.05

vs 25 benchmark

How BEAT Stacks Against Its Sector Peers

MetricBEAT ValueSector AveragePerformance
P/E Ratio-1.9528.62 Better (Cheaper)
ROE-1034.04%783.00% Weak
Net Margin0.00%-44009.00% (disorted) Weak
Debt/Equity0.000.39 Strong (Low Leverage)
Current Ratio0.744.12 Weak Liquidity
ROA-514.91%-21805.00% (disorted) Weak

BEAT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews HeartBeam, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-376.74%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-464.84%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ